Fewer than 10% of cancer patients undergo hereditary testing, meaning the vast majority of high-risk individuals are never identified within standard ...

Moneyview's IPO approval, fintech M&A activity, and fresh investments underscored July, where strategic expansion took centre ...

Learn how data center REITs fund AI/HPC growth via joint ventures and institutional capital, plus stocks to watch and rising ...

Scientists at the Icahn School of Medicine at Mount Sinai have uncovered the first high-resolution structure of NBCn2, a brain protein linked to epilepsy, autism spectrum disorder and other ...

Fragment-based drug discovery (FBDD) has emerged as a rigorous and efficient strategy for identifying lead compounds against structurally defined biological ...

Ancient dissections of Galen reveal a gap in modern medical training: tacit, hands-on skills still can’t be fully taught by digital tools. Tacit learning in medical education refers to the unwritten, ...

XtalPi has entered a strategic partnership with a biopharmaceutical company to develop oral small-molecule therapeutics targeting a GPCR.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Obesity may have met its match in GLP-1 receptor ...

Virtual screening can be approached in several ways, depending on whether the comparison is based on the known small molecule binders (ligands) or the target protein structure. Ligand-based virtual ...